Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2007
June 1, 2007
- Bristol-Myers Squibb Awards Immunicon New Research Services Agreement for Oncology Biomarker Development
- Isogenica Enters into Research and License Agreement with Wyeth
- Mylan Wins Omeprazole Patent Litigation
- Jazz Pharmaceuticals, Inc. Announces Initial Public Offering
- Nventa Consolidates Offices Into San Diego
- Black Horse Capital Opposes the Strategic Direction of Cypress Bioscience
- MOLOGEN AG Sells Spanish Subsidiary
- Revision - Decision Fails Patients with Transfusion-Dependent Anemia
- Termination of Development of Fixed Dose Combination Product of Actos + TAK-536
- AstraZeneca’s Prilosec Patents Upheld By Court
- Barr Confirms Decision in Azithromycin Inventorship Suit
- Pharmaceutical Blog Chatter Continues About Dr. Steven Nissen’s Avandia Revelations, Most Bloggers Refute
- Transition Therapeutics Acquires All Remaining Shares of NeuroMedix Inc.
- ImpaxX Announces Decision on Generic Prilosec Litigation
June 4, 2007
- Bayer Schering Pharma AG Will Terminate Registration With the U.S. SEC
- Final Data from a Phase 2 Trial Presented at ASCO Specifies Dose-dependent Activity of Adecatumumab (MT201)
- AstraZeneca Acquires Biologics Manufacturing Facility in Canada
- Cell Genesys and Medarex Report Follow-Up Data From a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
- New Data Evaluating Sutent, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
- Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
- GlaxoSmithKline Reports Positive New Data on Tykerb at the 2007 ASCO Annual Meeting
- Phase III Ixabepilone Study Demonstrated Significant Improvement in Progression-Free Survival in Patients With Advanced Metastatic Breast Cancer
- Telik Announces Top-Line Results of TELCYTA ASSIST-2 Trial
- Telik Reports Results of TELCYTA ASSIST-1 Trial
- Telik Reports Results of TELCYTA Assist-3 Trial
- Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac Weekly
- DTC Advertising Improvements Observed In Two New Reports
- FDA Announces New Advisory Committee to Address Risk Communication
June 5, 2007
- Neurogen Announces Continuing Preclinical and Clinical Development Work and Conclusion of Research Component of Collaboration for Investigational Pain Drug
- APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
- Eurand and GSK Reach Development Milestone
- Telik Announces Clinical Hold on TELCYTA Trials
- Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
- Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
- Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
- Valeant Pharmaceuticals Agrees to Sell Manufacturing Facilities in Basel, Switzerland and Humacao, Puerto Rico
- Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
- Mylan Wins Its Amlodipine Case With Pfizer
June 6, 2007
- GlaxoSmithKline Response to New England Journal of Medicine Editorials
- CRO Company Merger; A First for China's Drug Development Contract Research Organization Industry
- VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
- AstraZeneca CFO to Join Goldman Sachs
- WaferGen Completes Merger and Private Placement of $10.7 Million
- Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
- Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
- Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
June 7, 2007
- Takeda Revises Actos (pioglitazone HCl) Prescribing Label
- American Diabetes Association Strongly Advises Patients Using Rosiglitazone to See Their Doctor
- Roche Recalls Viracept Due to Chemical Impurity
- Agilent Technologies Adds Strength to Its Life Science Business With Acquisition of Stratagene
- Intertek Acquires QTI Laboratory
- Forbion Announces Successful Exit from Alantos Pharmaceuticals
- Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin
- Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa Patents
June 8, 2007
- Radiant Research Acquired by New Ownership Group
- Johnson & Johnson Highlights Growth Strategies for Pharmaceutical and Consumer Businesses
- Schering-Plough and Bayer Healthcare Announce Availability of ZETIA in Japan, the First Cholesterol-Lowering Agent With a Novel Mechanism of Action Approved in Japan in 18 Years
- On the Launch and Measures for Proper Use of the Anti-Cancer Agent Avastin
- Renovis Announces Achievement of Milestones in VR1 Collaboration with Pfizer Inc.
- Pharma Blogs This Week: Hot & Heavy Congressional Committee Hearings, DTC Study Shows No Effect on Pricing, and Another Pharma CFO Bites the Dust
- FDA Science Board to Meet on June 14
June 11, 2007
- ZARS, Inc. Files Registration Statement for Initial Public Offering
- Announcement of the Launch of the Selective COX-2 Inhibitor Celecox Tablets in Japan
- Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
- Archemix and Merck KGaA Sign Strategic Alliance
- AMRI Receives Milestone Payment From Licensing Agreement with Bristol-Myers Squibb
- Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
- Merck Signs Strategic Alliance With Archemix
- Pediatric Inhaled Corticosteroid Asthma Medication Features New Dose Counters to Help Track Usage
- Barr Announces Withdrawal of Zyprexa Zydis Patent Litigation
- Teva Receives Favorable Court Decision Regarding Generic Lotrel; Novartis' Motion for Preliminary Injunction Denied
- US Court Allows Teva to Resume US Sales of Its Generic Version of Lotrel
- Athersys Raises $65 Million in Concurrent Reverse Merger and Private Equity Offering
- U.S. Department of Justice Investigation of Bristol-Myers Squibb in Proposed Plavix Patent Settlement Is Resolved
June 12, 2007
- alli - The OTC Weight Loss Product - On Shelves Nationwide Later This Week
- Vical Receives $6 Million Grant From NIH to Advance RapidResponse DNA Vaccine Platform
- BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
- Kissei and Eisai sign a License Agreement to Develop and Commercialize Glufast, A Rapid-acting Insulin Secretagogue in 10 Asian Countries
- China Biopharma Signed LOI to Acquire All the Interest of a Chinese Regional Pharmaceutical Distribution Company
- Artes Medical Forms New Subsidiary to Commercially Develop and License Medical Applications of Its Microsphere Technology
- Repligen Reports Ruling on Sanctions Motion Against ImClone
June 13, 2007
- New Survey Shows Product Liability Litigation May Jeopardize Treatment Outcomes for People with Severe Mental Illnesses
- Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
- American Oriental Bioengineering Enters Into a Letter-of-Intent to Acquire Established Plant Based Pharmaceutical Company
- Reps. Hinchey & Stupak: FDA's Bond With Drug Industry Is As Strong As Ever
- Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest, Receives Request From the Independent Data Monitoring Committee to Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID
- Health Care Plans and Consumer Groups Unite and Call on Legislature to Pass Rx Gift Disclosure Law
June 14, 2007
- Interpublic Announces Development in SEC Investigation
- Charles River Laboratories Completes Chinese Joint Venture
- Canadian Levofloxacin Patent Upheld by Federal Appeal Court
- Cordis Corporation Resolves Corporate Warning Letter
June 18, 2007
- NicOx Provides an Update on NCX 4016
- Geron Increases Stake in TA Therapeutics Joint Venture
- FDA Converts Telcyta Full Clinical Hold to Partial Hold
- GlaxoSmithKline Expects to Launch Up to Five Major New Medicines for Oncology in Next Three Years
- Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
- Nabi Biopharmaceuticals Announces Creation of Biologics Business Unit & Provides Strategic Updates
- Merck & Co. Ordered to Pay Attorneys' Fees, Costs Following Vioxx Consumer Fraud Finding
- The Public is Doubtful that Strengthening the FDA's Oversight of the Prescription Drug Industry Will Make a Difference
June 19, 2007
- Roche Acquires NimbleGen to Gain Entry Into High-Growth Research Microarrray Market
- Regulatory Cooperation Expanded
- Verispan Reports: Biotech Companies Cut Sales Forces, but Managed Care Execs Want More Contact
- Bayer Raises Guidance for 2007 and 2009
- Diamyd Continues Invalidated Study
- ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
- Safety Measures for Oseltamivir Phosphate and Chugai's Future Approach
- Impax Announces Lawsuit Related to Generic Version of Depakote ER
- Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
- Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
- Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
- CuraGen to Close Pilot Manufacturing Plant
June 20, 2007
- Shire In-Licenses Juvista (Human TGFbeta3) From Renovo
- New Potential Treatment in Development for Patients Facing Heart Health Challenges
- Heygood, Orr, Reyes & Bartolomei: $5.5 Million Award in First Federal Fentanyl Patch Trial
- Proteros biostructures Announce Successful Achievement of Milestone in Fragment-Based Protein Crystallography Collaboration
- Texas Family Sues GlaxoSmithKline (GSK) Over Man's Heart Attack Death Following Avandia Use
- Pfizer Discontinues Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer
- Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
- Wyeth Responds to Verdict in Diet Drug Case
June 21, 2007
- Cardinal Health Completes Initial Tender Offer for VIASYS Healthcare
- WHI Study of Younger Postmenopausal Women Links Estrogen Therapy to Less Plaque in Arteries
- PharmalLive Releases from Pipeline to Market 2007, an Exclusive Annual Special Report
June 22, 2007
- Icagen Receives Notification from McNeil of Termination of Collaboration Agreement
- Viragen Streamlines Research Focus and Halts Further Development of OVA System
- Paion Reduces Number of Employees
- Barr Receives Approval for Generic Vesanoid Capsules, 10 mg
- European Medicines Agency Agrees on Action Plan Following the Recall of Viracept and Recommends Suspension of the Marketing Authorisation
- Pharma Bloggers Discuss Delay in Maraviroc Approval, Removal of Provisions in Prescription Drug User Fee Act, Triumph for Plavix Marketers, and More on Sicko
June 25, 2007
- AstraZeneca Announces Symbicort Is Now Available In The U.S.
- European Medicines Agency Recommends Restricted Use for Piroxicam
- Biodel Inc. Announces VIAject(TM) Data at Oral Presentation at the American Diabetes Association Meeting
- New Data Show Patients Treated With Avandia (Rosiglitazone Maleate) Incurred Lower Medical Costs and Used Fewer Healthcare Resources When Compared to Patients Treated With Sulphonylureas
- Roche and Toyama Chemical Enter Licensing Agreement to Develop Potential Breakthrough Drug to Treat Rheumatoid Arthritis
- Apidra Improved A1C In People With Type 2 Diabetes When Added to Basal Insulin and Oral Antidiabetic Treatments (BOT)
- Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
- Diabetes Patients Make Significant Gains in Disease Control; Still, Nearly Half Fail to Reach ADA Treatment Goals
- Coalition Urges American Medical Association to Halt Sale of Physician Data to Pharmaceutical Marketing Firms
- New Findings Show Half of Americans Surveyed Importing Drugs without a Prescription
- U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
June 26, 2007
- Ventana Advises Shareholders to Defer Taking Any Action in Response to Roche Offer
- UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
- Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations
- Pharma ChemOutsourcing Conference Posts Attendee List for September Custom Synthesis Blockbuster Show in New Jersey
- Commonly Prescribed Antidepressants Associated with Lower Bone Density in Older Men and Women
- NextBio Announces License Agreement with Genzyme
- Wyeth Licenses Drug Targets from Osteoporosis Collaboration with Galapagos
- Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology
- Daiichi Sankyo Commences Patent Litigation Against Mylan in the United States
- Organon Announces Acquisition of Kadmus Pharmaceuticals' FAAH Inhibitor Technology
- Pharsight Invited to Present on Oncology Modeling and Simulation at AAPS National Biotechnology Conference on June 28, 2007
- Biotechnology Council of New Jersey and Pennsylvania Bio to Host Seventh Annual Biosciences Symposium
- Amgen Submits Testimony to House Ways & Means Committee
- First Consulting Group Acquires Zorch, Inc.
- Clinquest Takes Stake in Enceladus
- Physicians Favor a DTC Moratorium More Strongly Than Consumers, though Both Groups Cite Public Safety as the Key Benefit, according to New TNS Healthcare Research
June 27, 2007
- inVentiv Health to Acquire AWAC, Leader in Providing Medical Cost Containment Services to Payors
- inVentiv Health to Acquire Chandler Chicco Agency
- FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
- Cardinal Health Reaffirms Fiscal 2008 Outlook; Raises Long-Term Profit Goals
- Vasogen Reports on Outcome of FDA Meeting
- Vermont Attorney General Sorrell Releases Pharmaceutical Company Report
- Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
- Biogen Idec Announces Preliminary Results of Its Modified ''Dutch Auction'' Tender Offer
- Roche Commences Tender Offer for Ventana for $75 Per Share in Cash
- Update on Migenix Agreement with Schering-Plough for Hepatitis C Virus Treatment
- VASTox Announces Significant Progress in Pharmaceutical Services Business
- Guideline and Med Ad News Host Panel to Discuss Issues Surrounding Patient Compliance
- MichBio Announces Its 2007 Expo; Bio CEO to be Keynote Speaker
- Spherix Signs Definitive Agreement for Sale of Information Subsidiary
June 28, 2007
- Pharsight Preferred Stockholders Elect to Convert Preferred Shares Into Common Stock
- Materia Licenses Metathesis Catalyst Platform to Eisai
- Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company's Institutional Investors on Corporate Governance Policies and Practices
- Isotechnika Will Be Represented at the Canadian Dermatology Annual Conference
- Bespak plc Exubera Update
- The General Public Supports Breaking Drug Patents To Ensure Access To HIV/AIDS Drugs In Poorer Countries
- Lawmakers Praise Committee Passage of Biologics Legislation
- Bioscience Leaders Discuss Strategies to Propel Industry, Innovations Throughout Southern California
- Cardinal Health Completes Subsequent Tender Offer for VIASYS Healthcare
- Thallion Announces Sale of Majority Stake in Caprion Proteomics to Great Point Partners
June 29, 2007
- Genmab Regains Rights to HuMax-CD4
- Lorus Therapeutics Announces Receipt of Court Approval for Proposed Plan of Arrangement
- Prescription Access Litigation: Federal Judge Allows Zyprexa Class Action to Go Forward
- Urigen N.A., Inc. Completes Shareholder Meeting
- Karo Bio Announces Delay in KB5359 Development
- Yet Another Pfizer Whistleblower Comes Forth Through Blogs, CME Criticism Continues, and Dr. Rost Gains Access to Astrazeneca Ethics Violation Website
- The International Society for Medical Publication Professionals (ISMPP) Publishes Position Paper on the Role of the Professional Medical Writer
- Combination of Sartorius Biotech Division and Stedim Completed
- Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
- RAPS Holds Japan Seminar, High-Ranking Officials Participate
